About 84,938 results

ALLMedicine™ Multiple Sclerosis Center

Research & Reviews  25,691 results

The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review.
Eye (London, England); Moheb N, Chen JJ

Mar 18th, 2023 - Optic neuritis (ON) is one of the most frequently seen neuro-ophthalmic causes of vision loss worldwide. Typical ON is often idiopathic or seen in patients with multiple sclerosis, which is well described in the landmark clinical trial, the Optic ...

A retrospective cohort study of patient-reported urinary tract infection signs and symp...
American Journal of Physical Medicine & Rehabilitation; Wirth M, Suda KJ et. al.

Mar 18th, 2023 - Characterize patient-reported signs and symptoms of urinary tract infections (UTI) in patients with neurogenic bladder (NB) to inform development of an intervention to improve the accuracy of UTI diagnosis. Retrospective cohort study, of adults wi...

Self-reported restrictions in different life domains and associated factors among peopl...
European Journal of Neurology; Teni FS, Machado A et. al.

Mar 18th, 2023 - The heterogeneous symptoms of multiple sclerosis (MS) can considerably impact the lives of people with MS (PwMS). The aim of this study was to describe the extent of restrictions in different life domains that PwMS experience in relation to their ...

Plant-based production of an orally active cyclotide for the treatment of multiple scle...
Transgenic Research; Jackson MA, Xie J et. al.

Mar 18th, 2023 - Multiple sclerosis (MS) is a debilitating disease that requires prolonged treatment with often severe side effects. One experimental MS therapeutic currently under development is a single amino acid mutant of a plant peptide termed kalata B1, of t...

First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug sip...
Theranostics Starke L, Millward JM et. al.

Mar 17th, 2023 - Theranostic imaging methods could greatly enhance our understanding of the distribution of CNS-acting drugs in individual patients. Fluorine-19 magnetic resonance imaging (19F MRI) offers the opportunity to localize and quantify fluorinated drugs ...

see more →

Guidelines  16 results

Supporting the Role of Parenting for People With Multiple Sclerosis: A Guide for Clinic...
Archives of Physical Medicine and Rehabilitation; Rider JV, Selim J

Jun 18th, 2022 - Supporting the Role of Parenting for People With Multiple Sclerosis: A Guide for Clinicians.|2022|Rider JV,Selim J,|

Vision Problems in Multiple Sclerosis.
Archives of Physical Medicine and Rehabilitation; Costa SL, Pandey K et. al.

Sep 29th, 2020 - Vision Problems in Multiple Sclerosis.|2020|Costa SL,Pandey K,Hrdina J,Rondon M,Devos H,|

Serum neurofilament light as a biomarker in progressive multiple sclerosis.
Neurology Kapoor R, Smith KE et. al.

Jul 18th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...

Practical Sleep Information for People With Multiple Sclerosis.
Archives of Physical Medicine and Rehabilitation; Siengsukon C, Karahan AY et. al.

May 14th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|

Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis...
Multiple Sclerosis and Related Disorders; Lebrun C, Vukusic S et. al.

Jun 5th, 2019 - To establish recommendations on immunization for patients with multiple sclerosis (MS) BACKGROUND: Vaccines have been suspected in the past to trigger MS and relapses. With the extension of the immunoactive treatment arsenal, other concerns have b...

see more →

Drugs  572 results see all →

Clinicaltrials.gov  2,675 results

Pilot Study of the Safety and Tolerability of L-DLPFC iTBS rTMS for MDD in MS

Mar 15th, 2023 - The main purpose of this study is to investigate the safety and tolerability of intermittent Theta Burst (iTBS), its effectiveness in alleviating depressive symptoms, concomitant neuropsychiatric symptoms such as anxiety and fatigue in people with...

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

Mar 10th, 2023 - Objectives. The primary aim of this pilot study is to assess the effects of short-term, high-dose corticosteroid administration on the 12-week evolution of multiple sclerosis lesions with centripetal enhancement pattern on magnetic resonance imagi...

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

Mar 10th, 2023 - The objective of this study is to examine the risk factors and natural course of JCV infection and progressive multifocal leukoencephalopathy (PML). PML is a devastating, demyelinating neurological disease affecting the brain of patients with a co...

Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

Mar 10th, 2023 - Cognitive impairment is common in and devastating to people with MS. MS is a common, chronic, central nervous system (CNS) disease characterized by inflammation, demyelination, and neurodegeneration. One of the most devastating symptoms of this di...

TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

Mar 10th, 2023 - Centra nervous system (CNF) damage in multiple sclerosis (MS), are mainly attributed to myelin destruction, axonal abnormalities and subsequent degeneration, and are responsible for serious deficiencies. Current therapies are focused on the treatm...

see more →

News  4,891 results

CHEST Unveils Guideline for Respiratory Management of Neuromuscular Diseases

Mar 16th, 2023 - Physicians should incorporate respiratory health care in early treatment plans for patients with neuromuscular diseases (NMD), according to new clinical guidelines from the American College of Chest Physicians (CHEST). Non-invasive ventilation, su...

No Increased MS Relapses for Women on Fertility Treatment

Mar 15th, 2023 - Fertility treatment was not associated with an increased risk of relapse in women with multiple sclerosis (MS) or clinically isolated syndrome (CIS), retrospective data showed. Across 80 cycles, the mean annualized relapse rate (ARR) 12 months bef...

MS looks homogeneous
Jim Kling

Mar 8th, 2023 - SAN DIEGO – Clinical characteristics and treatment responses in multiple sclerosis (MS) show unimodal distributions, which suggests that it is a homogeneous condition with lots of variation, rather than a mixture of conditions with different genet.

Portable MRI has potential for MS
Jim Kling

Mar 6th, 2023 - A blind comparison between a portable, ultra low-field magnetic resonance imaging (MRI) device and a traditional high-field MRI showed that the portable device performed well in detecting periventricular lesions in pateints with multiple sclerosis.

A better MS measure?
Jim Kling

Mar 2nd, 2023 - A digital tool to measure walking has the potential to improve measurement of disability among patients with multiple sclerosis (MS). “When you measure disability, what you really want to know is how things are changing in the patient’s life and n.

see more →

Patient Education  130 results see all →